SC 13G/A | 2017-01-25 | BlackRock Inc. | PROGENICS PHARMACEUTICALS INC | 5,544,263 | 7.9% | EDGAR |
SC 13G/A | 2016-02-16 | Broadfin Capital, LLC | PROGENICS PHARMACEUTICALS INC | 8,951,169 | 12.8% | EDGAR |
SC 13G/A | 2016-02-16 | BAKER BROS. ADVISORS LP | PROGENICS PHARMACEUTICALS INC | 4,350,808 | 6.2% | EDGAR |
SC 13G/A | 2016-02-11 | FEDERATED INVESTORS INC /PA/ | PROGENICS PHARMACEUTICALS INC | 13,508,290 | 19.4% | EDGAR |
SC 13G/A | 2016-01-27 | BlackRock Inc. | PROGENICS PHARMACEUTICALS INC | 4,844,445 | 6.9% | EDGAR |
SC 13G/A | 2015-02-17 | BAKER BROS. ADVISORS LP | PROGENICS PHARMACEUTICALS INC | 4,449,797 | 6.4% | EDGAR |
SC 13G/A | 2015-02-13 | FMR LLC | PROGENICS PHARMACEUTICALS INC | 5,242,279 | 7.5% | EDGAR |
SC 13G/A | 2015-02-11 | FEDERATED INVESTORS INC /PA/ | PROGENICS PHARMACEUTICALS INC | 13,508,290 | 19.4% | EDGAR |
SC 13G/A | 2015-01-26 | BlackRock Inc. | PROGENICS PHARMACEUTICALS INC | 5,081,535 | 7.3% | EDGAR |
SC 13G/A | 2014-07-21 | Broadfin Capital, LLC | PROGENICS PHARMACEUTICALS INC | 8,951,169 | 12.9% | EDGAR |
SC 13G/A | 2014-02-14 | FMR LLC | PROGENICS PHARMACEUTICALS INC | 6,171,046 | 10.1% | EDGAR |
SC 13G/A | 2014-02-14 | Broadfin Capital, LLC | PROGENICS PHARMACEUTICALS INC | 4,000,000 | 6.6% | EDGAR |
SC 13G/A | 2014-02-14 | TUDOR INVESTMENT CORP ET AL | PROGENICS PHARMACEUTICALS INC | 2,342,388 | 3.8% | EDGAR |
SC 13G | 2014-02-14 | BAKER BROS. ADVISORS LP | PROGENICS PHARMACEUTICALS INC | 4,200,000 | 6.9% | EDGAR |
SC 13G/A | 2014-02-12 | FEDERATED INVESTORS INC /PA/ | PROGENICS PHARMACEUTICALS INC | 12,549,790 | 20.6% | EDGAR |
SC 13G | 2014-01-30 | BlackRock Inc. | PROGENICS PHARMACEUTICALS INC | 4,467,285 | 7.3% | EDGAR |
SC 13G/A | 2013-07-09 | FEDERATED INVESTORS INC /PA/ | PROGENICS PHARMACEUTICALS INC | 12,549,790 | 21.1% | EDGAR |
SC 13G/A | 2013-02-14 | FMR LLC | PROGENICS PHARMACEUTICALS INC | 5,146,395 | 11.5% | EDGAR |
SC 13G/A | 2013-02-14 | TUDOR INVESTMENT CORP ET AL | PROGENICS PHARMACEUTICALS INC | 2,107,881 | 6.2% | EDGAR |
SC 13G/A | 2013-02-12 | FEDERATED INVESTORS INC /PA/ | PROGENICS PHARMACEUTICALS INC | 12,538,268 | 27.9% | EDGAR |